Found: 184
Select item for more details and to access through your institution.
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
- Published in:
- Catheterization & Cardiovascular Interventions, 2007, v. 69, n. 1, p. 73, doi. 10.1002/ccd.20897
- By:
- Publication type:
- Article
Utilization of catheterization and revascularization procedures in patients with non‐ST segment elevation acute coronary syndrome over the last decade.
- Published in:
- Catheterization & Cardiovascular Interventions, 2005, v. 66, n. 2, p. 149, doi. 10.1002/ccd.20469
- By:
- Publication type:
- Article
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF.
- Published in:
- EP: Europace, 2016, v. 18, n. 8, p. 1135, doi. 10.1093/europace/euv404
- By:
- Publication type:
- Article
Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration.
- Published in:
- Journal of Pharmacy Practice, 2020, v. 33, n. 5, p. 647, doi. 10.1177/0897190019828270
- By:
- Publication type:
- Article
Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.
- Published in:
- Biostatistics, 2011, v. 12, n. 2, p. 258, doi. 10.1093/biostatistics/kxq054
- By:
- Publication type:
- Article
The development of a mobile app‐focused deduplication strategy for the Apple Heart Study that informs recommendations for future digital trials.
- Published in:
- Stat, 2022, v. 11, n. 1, p. 1, doi. 10.1002/sta4.470
- By:
- Publication type:
- Article
Characteristics of Digital Health Studies Registered in ClinicalTrials.gov.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 9, p. 2041, doi. 10.1093/ndt/gfad009
- By:
- Publication type:
- Article
Design and development of a digital shared decision-making tool for stroke prevention in atrial fibrillation.
- Published in:
- JAMIA Open, 2023, v. 6, n. 1, p. 1, doi. 10.1093/jamiaopen/ooad003
- By:
- Publication type:
- Article
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial.
- Published in:
- Journal of Diabetes Research, 2022, p. 1, doi. 10.1155/2022/9998891
- By:
- Publication type:
- Article
The ARREST Pneumonia Clinical Trial. Rationale and Design.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
A Call for a New Paradigm for Diabetes Care in the Era of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i).
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care Database.
- Published in:
- Cardiology & Therapy, 2019, v. 8, n. 2, p. 329, doi. 10.1007/s40119-019-00147-5
- By:
- Publication type:
- Article
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF.
- Published in:
- Cardiology & Therapy, 2019, v. 8, n. 2, p. 283, doi. 10.1007/s40119-019-00146-6
- By:
- Publication type:
- Article
Acute Coronary Syndromes.
- Published in:
- Texas Heart Institute Journal, 2006, v. 33, n. 2, p. 187
- By:
- Publication type:
- Article
Canagliflozin review – safety and efficacy profile in patients with T2DM.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2019, v. 12, p. 209, doi. 10.2147/DMSO.S184437
- By:
- Publication type:
- Article
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 841, doi. 10.2147/COPD.S292978
- By:
- Publication type:
- Article
The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01832-5
- By:
- Publication type:
- Article
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program.
- Published in:
- Diabetologia, 2021, v. 64, n. 11, p. 2402, doi. 10.1007/s00125-021-05524-1
- By:
- Publication type:
- Article
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
- Published in:
- Diabetologia, 2021, v. 64, n. 10, p. 2147, doi. 10.1007/s00125-021-05512-5
- By:
- Publication type:
- Article
Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.
- Published in:
- Diabetologia, 2019, v. 62, n. 10, p. 1854, doi. 10.1007/s00125-019-4955-5
- By:
- Publication type:
- Article
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
- Published in:
- Diabetologia, 2019, v. 62, n. 6, p. 926, doi. 10.1007/s00125-019-4839-8
- By:
- Publication type:
- Article
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries.
- Published in:
- Clinical Cardiology, 2023, v. 46, n. 11, p. 1398, doi. 10.1002/clc.24109
- By:
- Publication type:
- Article
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
- By:
- Publication type:
- Article
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678
- By:
- Publication type:
- Article
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 758, doi. 10.1111/dom.15340
- By:
- Publication type:
- Article
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2151, doi. 10.1111/dom.15091
- By:
- Publication type:
- Article
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2043, doi. 10.1111/dom.15065
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCE.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 2038, doi. 10.1111/dom.15057
- By:
- Publication type:
- Article
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1413, doi. 10.1111/dom.14978
- By:
- Publication type:
- Article
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832
- By:
- Publication type:
- Article
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1927, doi. 10.1111/dom.14772
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1072, doi. 10.1111/dom.14671
- By:
- Publication type:
- Article
Effects of canagliflozin on major adverse cardiovascular events by baseline estimated glomerular filtration rate: Pooled Hispanic subgroup analyses from the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 12, doi. 10.1111/dom.14539
- By:
- Publication type:
- Article
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2707, doi. 10.1111/dom.14525
- By:
- Publication type:
- Article
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1652, doi. 10.1111/dom.14386
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 382, doi. 10.1111/dom.14226
- By:
- Publication type:
- Article
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2199, doi. 10.1111/dom.14143
- By:
- Publication type:
- Article
Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 46, doi. 10.1111/dom.13987
- By:
- Publication type:
- Article
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 530, doi. 10.1111/dom.13920
- By:
- Publication type:
- Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
- By:
- Publication type:
- Article
Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study-Renal ( CANVAS-R): A randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 387, doi. 10.1111/dom.12829
- By:
- Publication type:
- Article
Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment.
- Published in:
- Journal of Multidisciplinary Healthcare, 2014, v. 7, p. 137, doi. 10.2147/JMDH.S54324
- By:
- Publication type:
- Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2019, v. 40, n. 33, p. 2801, doi. 10.1093/eurheartj/ehz299
- By:
- Publication type:
- Article
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
- Published in:
- European Heart Journal, 2018, v. 39, n. 46, p. 4112, doi. 10.1093/eurheartj/ehy562
- By:
- Publication type:
- Article